The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 3.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:-
Acellular dermal matrices are used in reconstructive and cosmetic surgeries to repair or reconstruct anatomical defects. They provide three dimensional scaffolding that promotes tissue remodeling and wound healing.
Market key trends:-
The technological advancements in acellular dermal matrices to enhance reconstructive and cosmetic surgery outcomes has fueled their demand significantly. For instance, manufacturers are developing acellular dermal matrices derived from human and animal tissues that more closely mimic the mechanical properties and microstructure of native tissues. These next-generation matrices facilitate enhanced wound closure, tissue remodeling, and aesthetic outcomes post-surgery.
Segment Analysis:-
The U.S. acellular dermal matrices market is segmented into human tissue and porcine tissue. The porcine tissue segment dominated the market in 2023 and is expected to maintain its dominance during the forecast period. Porcine tissues are widely adopted owing to their lower cost as compared to human tissues and require lesser availability. Additionally, porcine tissues exhibit lesser risk of disease transmission as compared to human tissues.
Key Takeaways:-
The Global U.S. Acellular Dermal Matrices Market Growth is expected to witness high, exhibiting a CAGR of 3.8% over the forecast period, due to increasing prevalence of breast reconstruction procedures and hernia repair surgeries.
Regional analysis
North America dominated the market in 2023 and is expected to remain dominant during the forecast period. High obesity rates and increasing awareness about aesthetic procedures drive the market growth in this region.
Key players analysis
Key players operating in the U.S. Acellular Dermal Matrices market are Integra LifeSciences Corporation, AbbVie Inc., Johnson & Johnson, HansBioMed, Becton, Dickinson and Company, Cook Group, Smith & Nephew Plc., Reprise Biomedical, Organogenesis Holdings Inc., Tissue Regenix, LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, MiMedx Group, PolyNovo Limited, Fidia Pharma USA Inc., Baxter International Inc., In2Bones Global, BioHorizons, Inc., Harbor MedTech, Inc., MLM Biologics Inc., Geistlich Pharma AG, Olaregen Therapeutix, Inc., EnColl Corporation, Kerecis limited, DSM, ACell Inc., 3M, Cell Constructs I, LLC, Marine Polymer Technologies, Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.